(Q33541775)

27 July 2017

1 reference

title

Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy. (English)

1 reference

27 July 2017

1 reference

2

1 reference

27 July 2017

D Daelemans

1

1 reference

27 July 2017

E De Clercq

series ordinal

3

1 reference

27 July 2017

publication date

1 January 1999

1 reference

Antiviral Chemistry & Chemotherapy

27 July 2017

published in

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

1-14

1 reference

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Extracellular HIV-1 Tat Protein Induces a Rapid and Selective Activation of Protein Kinase C (PKC)-α, -ϵ, and -ζ Isoforms in PC12 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

D-Penicillamine inhibits transactivation of human immunodeficiency virus type-1 (HIV-1) LTR by transactivator protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of HIV-1 replication by a Tat RNA-binding domain peptide analog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

An overview of progress in antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

A lipidated anti-Tat antibody enters living cells and blocks HIV-1 viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

HIV-1 auxiliary proteins: making connections in a dying cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of HIV type 1 Tat-mediated trans-activation by oncostatin M in HLtat cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Differential inhibition of the DNA binding of transcription factors NF kappa B and OTF-1 by nitrogen mustard and quinacrine mustard: transcriptional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of human immunodeficiency virus type-1 env expression by C-5 propyne oligonucleotides specific for Rev-response element stem-loop V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

The trans-activator gene of HTLV-III is essential for virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

RNA recognition by the human immunodeficiency virus Tat and Rev proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Discovery and characterization of an HIV-1 Tat antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Control of RNA initiation and elongation at the HIV-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

The regulation of human immunodeficiency virus type-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

2-Glycineamide-5-chlorophenyl 2-pyrryl ketone, a non-benzodiazepin Tat antagonist, is effective against acute and chronic HIV-1 infections in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Tetrahydropyrimidine derivatives inhibit binding of a Tat-like, arginine-containing peptide, to HIV TAR RNA in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Selective inhibition of l kappaB alpha phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

CT-2576, an inhibitor of phospholipid signaling, suppresses constitutive and induced expression of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Alpha-lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition by doxorubicin of human immuno-deficiency virus (HIV) infection and replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

The HIV-1 inducer of short transcripts activates the synthesis of 5,6-dichloro-1-beta-D-benzimidazole-resistant short transcripts in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of human immunodeficiency virus type 1 long terminal repeat-driven transcription by an in vivo metabolite of oltipraz: implications for antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Ribozymes as potential anti-HIV-1 therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthranilic acid, a tryptophan metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Antioxidants inhibit stimulation of HIV transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Anti-human immunodeficiency virus drug combination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

A non-canonical base pair within the human immunodeficiency virus rev-responsive element is involved in both rev and small molecule recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Selective inhibition of mitogen-induced transactivation of the HIV long terminal repeat by carboxyamidotriazole. Calcium influx blockade represses HIV-1 transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000101

Harziphilone and fleephilone, two new HIV REV/RRE binding inhibitors produced by Trichoderma harzianum.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.49.990

Identifiers

DOI

10.1177/095632029901000101

1 reference

27 July 2017

1 reference